ResMed Inc (RME.HA)
| Previous close | 222.50 |
| Open | 224.70 |
| Bid | 228.10 x N/A |
| Ask | 228.60 x N/A |
| Day's range | 224.70 - 226.00 |
| 52-week range | 127.55 - 226.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 24 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireVaping Expected to Increase COPD Health and Economic Burden by 2050
New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non-Invasive Ventilation (NIV) enhancing survival rates. 88.7 million new COPD hospitalizations projected across Western Europe between 2019 - 2050Vaping projected to incur almost €30 billion additional direct and indirect costs by 2050€4.9 trillion projected cumulative cost to support
GuruFocus.comInsider Sale: Director Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)
On September 4, 2024, Peter Farrell, Director at ResMed Inc (NYSE:RMD), executed a sale of 2,000 shares of the company. The transaction was filed on the same day with the SEC. Following this transaction, the insider now owns 87,204 shares of ResMed Inc.
Simply Wall St.ResMed Insiders Sold US$16m Of Shares Suggesting Hesitancy
The fact that multiple ResMed Inc. ( NYSE:RMD ) insiders offloaded a considerable amount of shares over the past year...
